Aptamer hails two "key" contract wins; eyes revenue to beat prior year
(Alliance News) - Aptamer Group PLC on Friday announced new contracts as it expects annual revenue to further grow. Read More
| Price | 0.80p on 09-12-2025 at 12:40:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.85p |
| Sell | 0.75p |
| Last Trade: | Buy 120,668.00 at 0.8225p |
| Day's Volume: | 120,668 |
| Last Close: | 0.80p |
| Open: | 0.80p |
| ISIN: | GB00BNRRP542 |
| Day's Range | 0.80p - 0.80p |
| 52wk Range: | 0.23p - 1.30p |
| Market Capitalisation: | £21.58m |
| VWAP: | 0.8225p |
| Shares in Issue: | 2.70b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Aptamer Group (APTA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 120,668 | 0.8225p | Ordinary |
10:35:10 - 09-Dec-25 |
| Unknown* | 125,000 | 0.80p | Ordinary |
15:21:53 - 08-Dec-25 |
| Buy* | 6,135 | 0.8225p | Ordinary |
14:27:44 - 08-Dec-25 |
| Unknown* | 250,000 | 0.80p | Ordinary |
12:56:45 - 08-Dec-25 |
| Unknown* | 46,396 | 0.80p | Ordinary |
12:32:27 - 08-Dec-25 |
| Sell* | 669 | 0.7945p | Ordinary |
12:23:28 - 08-Dec-25 |
| Buy* | 121,285 | 0.8245p | Ordinary |
11:48:28 - 08-Dec-25 |
| Unknown* | 128,708 | 0.80p | Ordinary |
11:42:54 - 08-Dec-25 |
| Unknown* | 375,000 | 0.80p | Ordinary |
09:29:08 - 08-Dec-25 |
| Unknown* | 85,370 | 0.80p | Ordinary |
09:12:26 - 08-Dec-25 |
Aptamer Group (APTA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Nov 2025 1:01 pm | RNS | Results of 2025 Annual General Meeting |
| 27th Nov 2025 7:00 am | RNS | AGM Statement |
| 14th Nov 2025 7:00 am | RNS | Strong contract wins build commercial momentum |
| 4th Nov 2025 7:00 am | RNS | New contract with top five pharma company |
| 3rd Nov 2025 7:00 am | RNS | Posting of Annual Report and Notice of AGM |
| 14th Oct 2025 7:00 am | RNS | Full Year Results for the 12mths to 30 June 2025 |
| 13th Oct 2025 7:00 am | RNS | New contract with top 10 pharma |
| 10th Oct 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 8th Oct 2025 7:00 am | RNS | Major top 3 global pharma contract win |
| 26th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |